First In-person Eyecelerator Meeting to Focus on Where We Are, Where We’re Headed
Ophthalmology’s next-generation business conference will bring together leading ophthalmic companies and important new startups for fresh perspective
SAN FRANCISCO, Calif. – June 14, 2021 – Are you over Zoom meetings, too? Register today for the first in-person Eyecelerator™ conference, set for Thursday, July 22, at the Mandalay Bay Resort in Las Vegas. Get solid insight into the future of ophthalmology after a tumultuous year from today’s most influential ophthalmologists, the leadership of all the major ophthalmic companies, plus new entrepreneurial voices.
The Eyecelerator 2021 Conference series, a collaboration between the American Academy of Ophthalmology (AAO) and ASCRS (American Society of Cataract and Refractive Surgery), is designed for all innovation stakeholders, including entrepreneurs, executives, investors, and ophthalmologists. The meeting is held in conjunction with the ASCRS annual meeting. The next in-person Eyecelerator conference will be in November, in conjunction with the AAO’s annual meeting in New Orleans.
“We are excited to have all of the major ophthalmic companies assembled with novel and nimble startup companies that are innovating in the fields of dry eye, glaucoma and presbyopia,” said Program co-chair Eric D. Donnenfeld, MD. “These companies are opening up new markets through innovation, improving patient care and offering new modalities for ophthalmologists.”
“Ophthalmology is entering a new period of consolidation,” added Program co-chair Jim Mazzo. “I’m looking forward to insights from a panel discussion with leaders from healthcare payment, hospital systems, and private equity, as well as former Academy President Ruth Williams, MD, on the current state and future direction of ophthalmology.”
Program highlights include:
Mini Keynote: State of the Financial Markets
Chris Cooley, CFA, managing director at Stephens Inc., will offer a critical assessment of the challenges and opportunities in today's shifting health care markets.
Ophthalmic Consolidation: What it Means to You
An insightful discussion about industry consolidation from a variety of viewpoints, including hospitals, private practice, and equity investments.
Ophthalmology’s blue-chip companies examine the impact of COVID-19 on ophthalmic companies and where they'll focus resources in the coming years.
Find the full program here.
Johnson + Johnson Vision
Santen Pharmaceuticals, Ltd.
Bausch + Lomb
Eyecelerator, is a partnership between ASCRS (American Society of Cataract and Refractive Surgery) and the American Academy of Ophthalmology to connect entrepreneurs, investors, businesses and ophthalmologists to accelerate ophthalmic innovation and improve patient outcomes. For more information, visit https://eyecelerator.com.
ASCRS is an international educational society with ophthalmic surgeons at every career stage. Its mission is to empower anterior segment surgeons to improve the vision, outcomes and quality of life for their patients through innovative approaches to education, advocacy and philanthropy. For more information, visit ascrs.org.
About the American Academy of Ophthalmology
The Academy is the world’s largest association of eye physicians and surgeons. A global community of 32,000 medical doctors, it protects sight and empowers lives by setting the standards for ophthalmic education and advocating for its patients and the public. The Academy innovates to advance the profession and to ensure the delivery of the highest-quality eye care. Through its EyeSmart® articles on AAO.org, the Academy provides the public with the most trusted information about eye health. For more information, visit aao.org.